All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Valganciclovir prophylaxis against cytomegalovirus impairs lymphocyte proliferation and activation in renal transplant recipients

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11140%2F11%3A10104743" target="_blank" >RIV/00216208:11140/11:10104743 - isvavai.cz</a>

  • Result on the web

    <a href="http://dx.doi.org/10.3851/IMP1879" target="_blank" >http://dx.doi.org/10.3851/IMP1879</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.3851/IMP1879" target="_blank" >10.3851/IMP1879</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Valganciclovir prophylaxis against cytomegalovirus impairs lymphocyte proliferation and activation in renal transplant recipients

  • Original language description

    Adult renal transplant recipients were assigned to 3-month prophylaxis with either valganciclovir (900mg q.d., n=19) or valacyclovir (2g q.i.d., n=17) as part of an ongoing randomized trial. Subsets of lymphocytes, lymphocyte proliferation and/or cytokine production after in vitro mitogen stimulation were evaluated at the end of prophylaxis and one month after withdrawal of antiviral drugs. Lymphocyte proliferation was significantly decreased both after phytohemagglutinine (25+-15 vs. 32+-18%, P=0.025)and concanavalin A stimulation (17+-9 vs. 25+-16%, P=0.011) during valganciclovir, but not valacyclovir therapy. Moreover, a lower activated T cell count (CD3+HLA-DR+ cells) was noted in valganciclovir-treated patients (13+-10 vs. 17+-12% of total CD3+ Tcells, P=0.005). Conclusions: Valganciclovir suppresses lymphocyte proliferation and activation in patients after renal transplantation.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

  • CEP classification

    FJ - Surgery including transplantology

  • OECD FORD branch

Result continuities

  • Project

  • Continuities

    Z - Vyzkumny zamer (s odkazem do CEZ)

Others

  • Publication year

    2011

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Antiviral Therapy

  • ISSN

    1359-6535

  • e-ISSN

  • Volume of the periodical

    16

  • Issue of the periodical within the volume

    8

  • Country of publishing house

    GB - UNITED KINGDOM

  • Number of pages

    9

  • Pages from-to

    1227-1235

  • UT code for WoS article

  • EID of the result in the Scopus database